Skip to content
healthcare.dev
Get a free key

Cinryze

NDC 42227-083, HUMAN C1-ESTERASE INHIBITOR, kit, from Takeda Pharmaceuticals America, Inc..

Product NDC
42227-083
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
KIT
Route
—
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125267
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42227-083 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
42227-083-01422270083011 KIT in 1 CARTON (42227-083-01) * 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) * 5 mL in 1 VIAL, GLASS (64764-515-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=42227-083

Use it

Look up 42227-083 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42227-083 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42227-083. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.